Skip to main content

Table 3 Comparison of patients who received albumin and those who did not

From: Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study

 

All patients (n = 3,147)

Albumin (n = 354)

No albumin (n = 2,793)

p value

SOFA score, mean ± SD

5.2 ± 3.9

7.2 ± 4.2

4.9 ± 3.8

<0.001

Sepsis syndromes (%)

    

   Sepsis

765 (24.3)

128 (36.2)

637 (22.8)

<0.001

   Severe sepsis

549 (17.4)

109 (30.8)

440 (15.8)

<0.001

   Septic shock

241 (7.7)

60 (16.9)

181 (6.5)

<0.001

Procedures (%)

    

   Mechanical ventilation

1,853 (58.9)

269 (76.0)

1,584 (56.7)

<0.001

   Pulmonary artery catheter

378 (12.0)

74 (20.9)

304 (10.9)

<0.001

   Hemofiltration

82 (2.6)

23 (6.5)

59 (2.1)

<0.001

   Hemodialysis

57 (1.8)

13 (3.7)

44 (1.6)

0.005

Organ failure (%)

    

   Respiratory

705 (22.4)

111 (31.4)

594 (21.3)

<0.001

   Cardiovascular

784 (24.9)

156 (44.1)

628 (22.5)

<0.001

   Coagulation

158 (5.0)

42 (11.9)

116 (4.2)

<0.001

   Hepatic

89 (2.8)

19 (5.4)

70 (2.5)

0.002

   Renal

562 (17.9)

76 (21.5)

486 (17.4)

0.060

   Neurological

681 (21.6)

71 (20.1)

610 (21.8)

0.443

  1. Sequential organ failure assessment (SOFA) score, sepsis syndromes, procedures, and organ failure (SOFA > 2) in patients who did and did not receive albumin compared with admission values for patients who did not receive albumin.